HIV epidemiology in Greece

Future Microbiology

Volumn 3, Issue 5, 2008, Pages 507-516

  Nikolopoulos, G ^a   Paraskevis, D ^a   Hatzakis, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Genetic heterogeneity; Greece; HIV; MSM; Subtypes

Indexed keywords

PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ANTIVIRAL RESISTANCE; ARTICLE; BLOOD TRANSFUSION; DRUG ABUSE; GENETIC HETEROGENEITY; GREECE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INSECT BITE; MOLECULAR EPIDEMIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTITUTION; SEXUAL INTERCOURSE; VIRUS MUTATION; VIRUS TRANSMISSION; ADULT; CLASSIFICATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MALE; MORTALITY; SUBSTANCE ABUSE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; GENOTYPE; GREECE; HETEROSEXUALITY; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; POLYMORPHISM, GENETIC; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 55449128698     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.5.507     Document Type: Article

References (66)

1. UNAIDS/WHO. Jointed United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) AIDS epidemic Update. Geneva: UNAIDS (2007).
2. Hamers FF, Downs AM: The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet 364(9428), 83-94 (2004).
3. Mocroft A, Vella S, Benfield TL et al.: Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352(9142), 1725-1730 (1998).
4. HCDCP. Hellenic Center for Diseases Control and Prevention (HCDCP). HIV/ AIDS Surveillance Report in Greece. 31 December (2007).
5. EuroHIV. HIV/AIDS Surveillance in Europe. End-year report 2006. Saint-Maurice, Institut de vaille sanitaire (2007).
6. HCDCP. Hellenic Center for Diseases Control and Prevention (HCDCP). HIV/ AIDS Surveillance Report in Greece. 21, 31 December (2006).
7. Nikolopoulos G, Konte V, Masgala A, Eleni E, Tsantes A, Paraskeva D: Surveillance data on paediatric HIV infection and AIDS in Greece. Euro. Surveill. 9, 9-11 (2004).
8. Masgala A, Nikolopoulos G, Tsantes A, Paraskeva D: Epidemiology of AIDS defining conditions in Greece. Cent. Eur. J. Public Health 12(4), 201-206 (2004).
9. Malliori M, Sypsa V, Psichogiou M et al.: A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction 93(2), 243-251 (1998).
10. Arvanitis M, Nikolopoulos G, Masgala A, Paraskeva D, Eleni E: Survival analysis of cases presenting AIDS from time of diagnosis to death. Presented at: 9th European AIDS Conference (EACS). Warsaw. Poland, 25-29 October 2003.
11. Raftopoulos V, Nikolopoulos G, Konte V et al.: HIV/AIDS mortality in Greece: Analysis of 1,739 deaths during 1983-2005. Presented at: International Council of Nurses Conference. Yokohama. Japan, 27 May-1 June 2007.
12. Europe. WHO Regional Office for Europe. Preliminary Report: Outcomes of the WHO/Europe Surveys on HIV/AIDS and Antiretroviral therapy 2002-2006 (2007).
13. Kyriopoulos JE, Geitona MA, Paparizos VA et al.: The impact of new antiretroic therapeutic schemes on the cost for AIDS treatment in Greece. J. Med. Syst. 25(1), 73-80 (2001).
14. Tsiara C, Nikolopoulos G, Makri E, Pilli M, Raftopoulos V, Paraskeva D: Cost assesment of highly active antiretroviral therapy in Greece, during the period 1996-2005. Presented at: 1st International Conference of the journal Public Health. Lisbon, Portugal, 9-11 May 2007.
15. Eurostat. Non-national populations in the EU Member States. Statistics in focus, Population and social conditions (2006).
16. Nikolopoulos G, Arvanitis M, Masgala A, Paraskeva D: Migration and HIV epidemic in Greece. Eur. J. Public Health 15(3), 296-299 (2005).
17. Likatavicius G, Hamers FF, Downs AM, Alix J, Nardone A: Trends in HIV prevalence in blood donations in Europe, 1990-2004. AIDS 21(8), 1011-1018 (2007).
18. EuroHIV. HIV/AIDS Surveillance in Europe. Mid-year report 2005. Saint-Maurice, Institut de vaille sanitaire (2006).
19. Laperche S: Blood safety and nucleic acid testing in Europe. Euro. Surveill. 10(2), 3-4 (2005).
20. UNAIDS. Jointed United Nations Programme on HIV/AIDS (UNAIDS). 2006 Report on the global AIDS epidemic. Geneva (2006).
21. Merakou K, Costopoulos C, Marcopoulou J, Kourea-Kremastinou J: Knowledge, attitudes and behaviour after 15 years of HIV/AIDS prevention in schools. Eur. J. Public Health 12(2), 90-93 (2002).
22. Petridou E, Polychronopoulou A, Hatzakis A et al.: The AIDS profile in a low risk country: the central role of bisexual men. J. Epidemiol. Biostat. 5(5), 285-292 (2000).
23. EuroHIV. HIV/AIDS Surveillance in Europe. Mid-year report 2007. Saint-Maurice, Institut de vaille sanitaire (2007).
24. Point. GRF. 2006 National Report (2005 data) to the EMCDDA. Greek Reitox Focal Point, Athens (2006).
25. EMCDDA. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2007 - the state of the drugs problem in Europe. Lisbon (2007).
26. Papaevangelou G, Roumeliotou A, Stergioy G et al.: HIV infection in Greek intravenous drug users. Eur. J. Epidemiol. 7(1), 88-90 (1991).
27. Koulierakis G, Gnardellis C, Agrafiotis D, Power KG: HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction 95(8), 1207-1216 (2000).
28. Koullerakis G: Drug use and related precautions prior to imprisonment, inside prison and intentions after release among Greek inmates. Addict. Res. Theory 14, 217-233 (2006).
29. Papadogeorgaki H, Caroni C, Frangouli E et al.: Prevalence of sexually transmitted infections in female sex workers in Athens, Greece - 2005. Eur. J. Dermatol. 16(6), 662-665 (2006).
30. Peeters M, Honore C, Huet T et al.: Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS 3(10), 625-630 (1989).
31. Gao F, Bailes E, Robertson DL et al.: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397(6718), 436-441 (1999).
32. Hahn BH, Shaw GM, De Cock KM, Sharp PM: AIDS as a zoonosis: scientific and public health implications. Science 287(5453), 607-614 (2000).
33. Sharp PM, Bailes E, Gao F et al.: Origins and evolution of AIDS viruses: estimating the time-scale. Biochem. Soc. Trans. 28(2), 275-282 (2000).
34. Thomson MM, Najera R: Increasing HIV-1 genetic diversity in Europe. J. Infect. Dis. 196(8), 1120-1124 (2007).
35. Apetrei C, Necula A, Holm-Hansen C et al.: HIV-1 diversity in Romania. AIDS 12(9), 1079-1085 (1998).
36. Brunet JB, Bouvet E, Massari V: Epidemiological aspects of acquired immune deficiency syndrome in France. Ann. NY Acad. Sci. 437, 334-339 (1984).
37. Glauser MP, Francioli P: Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe. Eur. J. Clin. Microbiol. 3(1), 55-58 (1984).
38. Clumeck N, Sonnet J, Taelman H et al.: Acquired immunodeficiency syndrome in African patients. N. Engl. J. Med. 310(8), 492-497 (1984).
39. Bobkov A, Cheingsong-Popov R, Selimova L et al.: An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain. AIDS Res. Hum. Retroviruses 13(14), 1195-1201 (1997).
40. Paraskevis D, Magiorkinis F, Magiorkinis G et al.: Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. J. Infect. Dis. 196(8), 1167-1176 (2007).
41. Paraskevis D, Wensing AMJ, Vercauteren J et al.: on behalf of the SPREAD-programme. Prevalence of HIV-1 subtypes among newly HTV-1 diagnosed individuals during 2002-2003 in Europe: Evidence for a continuous introduction of non-B subtypes. Presented at: 1st International Workshop on HIV Transmission. Toronto, Canada, 11-12 August 2006 (Abstract 34).
42. Nasioulas G, Paraskevis D, Magiorkinis E, Theodoridou M, Hatzakis A: Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. AIDS Res. Hum. Retroviruses 15(8), 745-758 (1999).
43. Paraskevis D, Magiorkinis E, Magiorkinis G et al.: Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype. J. Gen. Virol. 82(Pt 10), 2509-2514 (2001).
44. Paraskevis D, Magiorkinis E, Magiorkinis G et al.: Phylogenetic reconstruction of a known HIV-1 CRF04∐x transmission network using maximum likelihood and Bayesian methods. J. Mol. Evol. 59(5), 709-717 (2004).
45. Paraskevis D, Magiorkinis E, Katsoulidou A et al.: Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. Virus Res. 112(1-2), 115-122 (2005).
46. Paraskevis D, Magiorkinis G, Magiorkinis E et al.: Patterns of HIV-1 genotypic drug resistance among antiretroviral experienced patients in Greece during 1999-2006. In: 11th European AIDS Conferance/EACS. Madrid, Spain, 24-27 October 2007.
47. Tsantes A, Nikolopoulos G, Masgala A, Paraskeva D: Assessing the secular trends in the transmission of HIV in Greece. Sex Transm. Infect. 81(3), 230-232 (2005).
48. Read TR, Hocking J, Sinnott V, Hellard M: Risk factors for incident HIV infection in men having sex with men: a case-control study. Sex Health 4(1), 35-39 (2007).
49. Elford J, Bolding G, Maguire M, Sherr L: Combination therapies for HIV and sexual risk behavior among gay men. J. Acquir. Immune Defic. Syndr. 23(3), 266-271 (2000).
50. Elford J, Bolding G, Sherr L: High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism? AIDS 16(11), 1537-1544 (2002).
51. Huebner DM, Rebchook GM, Kegeles SM: A longitudinal study of the association between treatment optimism and sexual risk behavior in young adult gay and bisexual men. J. Acquir. Immune Defic. Syndr. 37(4), 1514-1519 (2004).
52. International Collaboration on HIV Optimism: HIV treatments optimism among gay men: an international perspective. J. Acquir. Immune Defic. Syndr. 32(5), 545-550 (2003).
53. Elford J, Bolding G, Sherr L: Seeking sex on the Internet and sexual risk behaviour among gay men using London gyms. AIDS 15(11), 1409-1415 (2001).
54. Van de Ven P, Mao L, Fogarty A et al.: Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS 19(2), 179-184 (2005).
55. Liau A, Millett G, Marks G: Meta-analytic examination of online sex-seeking and sexual risk behavior among men who have sex with men. Sex Transm. Dis. 33(9), 576-584 (2006).
56. Mustanski BS: Are sexual partners met online associated with HIV/STI risk behaviours? Retrospective and daily diary data in conflict. AIDS Care 19(6), 822-827 (2007).
57. Des Jarlais DC, Semaan S: HIV prevention for injecting drug users: the first 25 years and counting. Psychosom. Med. 70(5), 606-611 (2008).
58. Ball AL: HIV, injecting drug use and harm reduction: a public health response. Addiction 102(5), 684-690 (2007).
59. Metzger DS, Navaline H: HIV prevention among injection drug users: the need for integrated models. J. Urban Health 80(4 Suppl. 3), iii59-66 (2003).
60. Sylla L, Bruce RD, Kamarulzaman A, Altice FL: Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int. J. Drug Policy 18(4), 306-312 (2007).
61. Vickerman P, Kumaranayake L, Balakireva O et al.: The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine. Sex Transm. Dis. 33(10 Suppl), S89-102 (2006).
62. Kumaranayake L, Vickerman P, Walker D et al.: The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction 99(12), 1565-1576 (2004).
63. Jacobs P, Calder P, Taylor M et al.: Cost effectiveness of Streetworks' needle exchange program of Edmonton. Can. J. Public Health 90(3), 168-171 (1999).
64. Vlahov D, Junge B: The role of needle exchange pmgrams in HIV prevention. Public Health Rep. 113(Suppl. 1). 75-80 (1998).
65. Des Jarlais DC, Kling R, Hammett TM et al.: Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project. AIDS 21(Suppl 8), S109-114 (2007).
66. Foss AM, Watts CH, Vickerman P et al.: Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka. Bangladesh? Addiction 102(1), 114-125 (2007).